Table 4.
N | All-cause mortality HR (95% CI) P-value | P for log likelihood ratio test | Cardiovascular mortality HR (95% CI) P-value | P for log likelihood ratio test | |||
---|---|---|---|---|---|---|---|
Cutoff value, mmol/l | <158 | ≥158 | <190 | ≥190 | |||
Age | |||||||
≥65 | 4,323 | 0.95 (0.93, 0.98) <0.001 | 1.00 (0.98, 1.03) 0.769 | 0.021 | 1.00 (0.96, 1.04) 0.896 | 1.02 (0.94, 1.11) 0.669 | 0.777 |
<65 | 7,846 | 0.93 (0.89, 0.97) <0.001 | 1.03 (1.01, 1.06) 0.018 | <0.001 | 0.95 (0.89, 1.02) 0.164 | 1.11 (1.07, 1.15) <0.001 | 0.002 |
Gender | |||||||
Male | 5,783 | 0.91 (0.88, 0.93) <0.001 | 1.04 (1.01, 1.07) 0.014 | <0.001 | 0.95 (0.91, 1.00) 0.046 | 1.12 (1.07, 1.17) <0.001 | <0.001 |
Female | 6,386 | 0.97 (0.94, 1.01) 0.117 | 1.01 (0.98, 1.04) 0.396 | 0.149 | 1.01 (0.96, 1.07) 0.63 | 1.03 (0.94, 1.13) 0.517 | 0.787 |
Race | |||||||
Non-white | 6,757 | 0.93 (0.90, 0.96) <0.001 | 1.04 (1.01, 1.07) 0.003 | <0.001 | 0.97 (0.93, 1.02) 0.204 | 1.11 (1.06, 1.17) <0.001 | 0.002 |
White | 5,412 | 0.95 (0.92, 0.98) <0.001 | 1.01 (0.98, 1.04) 0.462 | 0.015 | 1.00 (0.95, 1.05) 0.999 | 1.06 (0.98, 1.15) 0.157 | 0.327 |
Lipid-lowering drugs | |||||||
No | 9,768 | 0.93 (0.91, 0.96) <0.001 | 1.02 (1.00, 1.05) 0.034 | <0.001 | 0.98 (0.95, 1.02) 0.397 | 1.09 (1.04, 1.14) <0.001 | 0.013 |
Yes | 2,401 | 0.96 (0.91, 1.00) 0.061 | 1.03 (0.98, 1.09) 0.25 | 0.086 | 0.99 (0.91, 1.07) 0.779 | 1.11 (1.01, 1.22) 0.024 | 0.136 |
Body mass index, kg/m2 | |||||||
<25 | 2,422 | 0.92 (0.88, 0.95) <0.001 | 1.03 (0.98, 1.08) 0.227 | 0.002 | 0.98 (0.93, 1.05) 0.6 | 1.07 (0.93, 1.23) 0.323 | 0.346 |
≥25 | 9,491 | 0.95 (0.92, 0.98) <0.001 | 1.03 (1.00, 1.05) 0.023 | <0.001 | 0.99 (0.95, 1.03) 0.699 | 1.10 (1.05, 1.15) <0.001 | 0.009 |
When analyzing a subgroup variable, age, gender, race, smoking, body mass index, systolic blood pressure, diabetes, and medicine use (antihypertensive drugs, hypoglycemic agents, and lipid-lowering drugs) were all adjusted except the variable itself.